39^th World Cancer Conference

About Conference

The 39^th World Cancer Conference is scheduled for November 25-26, 2020 in Rome, Italy. World Cancer 2020 invites all the participants from all over the world which includes prompt Keynote talks, Oral talks, Poster presentations, Sponsor Ships and Exhibitions.

The aim of this conference is “Amalgamation of innovations in cancer treatment”.

World Cancer 2020 is comprised of many interactive scientific sessions as well as various diagnostic and therapeutic advancements in cancer. It is an initiative to unite the diverse research and business communities working in this field under a one roof to explore every single aspect of oncology.

Importance & Scope

World Cancer 2020 will be the best platform for all the oncologists, haematologists, research scholars, students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability and quality of life.

According to market study, annual global growth in the oncology drug market is expected to be 7.5–10.5 percent through 2020, reaching $150 billion. Wider utilization of new products - especially immunotherapies - will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes. Payers also are expected to tighten their negotiation stance with manufacturers and adopt new payment models in an effort to drive greater value from their expenditures on these drugs.

The World Cancer 2020 is the premier event that brings together International experts, Training Institutes, Manufacturing Medical Devices Companies, Business Entrepreneurs, Medical Colleges, Researchers, Academicians, Physicians, Post Docs, Students, Pharmacy Industries, Academic scientists, Industry professionals, Diagnostic laboratory professionals and decision makers across the globe to exchange their knowledge, experience and research innovations to build Cancer Research scientists to reduce the global burden of cancer.

World Cancer 2020 is an extraordinary event designed for International medical health professionals and oncologists to facilitate the dissemination and application of new research findings related to Cancer. The conference invites participants from all leading universities, clinical research institutions and diagnostic companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the latest techniques.

Why you should attend World Cancer 2020??

International conferences are great opportunities not only for researchers and scientists, but also for experts, policy makers, stakeholders and students. Here are six reasons for you to attend International conferences in your field. There is an abundance of academic conferences today as compared to the past. This brings us to a simple question, “Why should one attend an academic conference?” Below are reasons why people say they attend our conferences.

At a conference, innovative ideas are thrown about and new information is exchanged among experts. Its purpose could be one of the following: An academic conference is a gathering of scientists or academicians, where research findings are presented or a workshop is conducted.

Attending a seminar has numerous benefits, including improving communication skills, gaining expert knowledge, networking with others and renewing motivation and confidence.

Learning: Attending conferences, especially the international ones, gives you the chance to listen to different points of view and learn new ideas and trends in your field. They also provide you with new techniques, new types of equipment, data that is yet to be published, and investigators that you may not have heard of. Conferences are priceless chances to sharpen your saw by learning new skills in a different environment.

Discussion: Attending conferences allows you to learn new information and tactics from hearing others’ presentations, you also can converse with other researchers from different universities and even countries you may have only heard or read about.

Presentation: Presenting your research in a conference helps you in different ways. It presents your work to the scientific circles and helps to improve your work by getting feedback from the experts and influencers in your field. Presenting a paper is one of the main objectives of an academic conference participant. The presenter will have the chance to present a paper in front of colleagues of the same or similar fields of study and will be able to receive positive feedback and constructive criticism about their research. The exchange of ideas on fields of interests seeds the links for future collaborations across the world. There are many who were once GAI conference participants now developing research projects and writing papers together.

Visiting a new place: Attending conferences allows you to discover a new place or city where the conference is being held and learn about its people and culture. Many conferences support their attendees with a list of great places they can visit in the conference’ city or country. You can also extend your participation in the conference to a well-deserved holiday in that country and have memorable days.

Networking for future collaborations: International Conferences are great opportunities to connect with attendees from different perspectives and views, learn from them, make new relationships, and strengthen existing ones. Conferences pave the way for scientific cooperation by meeting and connecting with researchers from different countries. They also help in cooperating collective research projects such as edited books, special issues in peer-reviewed journals or funding applications. In addition, Conferences allow Experts, Stakeholders and Policymakers to communicate with researchers with innovative approaches and benefit from these relations in their businesses. Attending an academic conference is an opportunity to build networks with other academics and experts in the same or similar field of studies all around the world and to share thoughts on recent advances and technological breakthroughs. It is an opportunity to expand the knowledge that one has and upgrade performance in accomplishing institutional objectives. Conferences bring together people who share a common discipline from different parts of the world, bringing different forms of ideas which build into something greater.  As you step up and attend conferences you build a network of people who can raise your calibre of work to greater heights as you achieve shared objectives.

Academic Reputation: Attending important international conferences will make you a known figure in academic circles, not to mention the benefits for your resume as it will create an impression that you are an active member of the academic community.

Travelling: An academic conference is a great way to have a “break” from your academic responsibilities at the university and discover different cities of the world. Be assured that you’ll feel relaxed and refreshed when you return to your institution after the conference.

Added Research Value: For students and researchers, academic conferences help to make research on a particular subject easier. They provide access to various research activities related to a particular subject with current findings and developments anticipated from them.

Publication: Another common reason for attending a conference is no doubt publication. Conference proceedings are always a good way to have your research published and indexed. You’ll also have the opportunity to publish your research in one of the journals.

Socialization and the culture factor: Meeting new people with different cultures and dispositions enlightens your way of thinking in your field of study. You will witness some of the many different aspects and solutions which exist on the same issues. You’ll also have the chance to socialize with your colleagues at coffee breaks, lunches and social activities. Imagine a conference without socializing or learning more about other people’s cultural tradition? This cannot be summed up adequately as people from different parts of the world who have uniqueness in their ways of living which you are often surprised to learn from.

Find out what’s new: It is vital to find out what’s new in your field of study to survive in an academic discipline. Academic conferences will keep you updated on new findings that have taken place. This is in fact one of the major reasons why one should attend an academic conference.

The focus and energy of Like-Minded Individuals: When one attends an academic conference he or she is sure to meet people of his or her same stature, mindset and goals. This is a motivational factor as one aspires to overcome fears and achieve one’s dreams.

Conclusion:

In today’s fast changing world, attending a conference has become a “must” to survive in an academic discipline. Many academics have become aware of this fact as the number of conferences and participants increase dramatically. We look forward to collaborating with you at World Cancer 2020.

Enlightening public with recent advances in Cancer diagnosis and therapy from around the world focused on cancer about recent advances in Cancer diagnosis and therapy, this is your single best opportunity to reach the largest assemblage of participants. World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are hallmarks of this conference. Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Oncology and Cancer.

Who Should Attend World Cancer 2020??

Oncologists, Radiologists, Chemotherapists, Physicians, Academicians, Industry professionals, Diagnostic laboratory professionals, Academic scientists, Postgraduate students, Postdoctoral fellows, and Trainees can attend

All individuals engaged in cancer care operations should attend the “37th World Cancer Conference”, including:

• Hospital presidents/CEOs/COOs/VPs/trustees
• Hospital c-suite executives (operations, development, finance)
• Medical directors
• Oncology specialists (medical, radiation, and surgical)
• Oncology program and practice administrators, managers, and service line executives
• Healthcare consultants, vendors, and suppliers
• Pharmaceutical and biotechnology manufacturers
• Cancer program marketing and public relations professionals

How to find a virtuous conference??

Before you sign up, think about what you hope to gain from attending. Look for a conference that matches your goals for fellowship, medical knowledge, and/or new skills. And you may be surprised at how many opportunities arise.

Conference Series, which organizes 3000+ Global events, 1200+ Symposiums and 1200+Workshops every year is delighted to welcome all the enthusiastic participants across the world to its prestigious Conference on ‘39th World Cancer Conference’ which is going to be held during November 25-26, 2020 in Rome, Italy.

World Cancer 2020 provides an excellent opportunity to share views, exchange knowledge and establish research collaborations & networking.

.Guidelines for Young Researchers Forum

Benefits

• Young Scientist Award recongination certificate and memento to the winners.
• Our conferences provide best Platform for your research through oral presentations.
• Learn about career improvement with all the latest technologies by networking.
• Young Scientists will get appropriate and timely information by this Forum.
• Platform for collaboration among young researchers for better development.
• Provide an opportunity for research interaction and established senior investigators across the globe in the field.
• Share the ideas with both eminent researchers and mentors.
• It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge.

Sessions/Tracks

Conference Series LLC LTD invites all the participants across the globe to attend the “39^th World Cancer Conference” scheduled during November 25-26, 2020 at Rome, Italy.

As the theme of the conference emphasises ‘Amalgamation of innovations in cancer treatment’, the Conference is an outstanding international forum to present and discuss progress in exploration, expansion, ideals, and applications of the topics related to the Cancer & Oncology.

In addition to the multidisciplinary talks, Keynote sessions, and lectures relevant to cancer & oncology research, the World Cancer 2020 is a complete 2-day event with panel discussions.

World Cancer 2020 has been designed with many interesting and informative scientific sessions; it includes all possible aspects of oncology research.

The conference is CME & CPD Accredited.

Scientific Sessions:

Track 1: Cancer Cell Biology & Genetics  

Cancer is caused when cells within the body accumulate genetic mutations and start to grow in an uncontrolled manner. Understanding how cancer develops and progresses, including how gene mutations drive the growth and spread of cancer cells, and how tumours interact with their surrounding environment, is vital for the discovery of new targeted cancer treatments.

Related Conferences
32nd International Conference on Cancer Research and Therapy during February 19-20-2020 at Osaka, Japan; 4th Global Summit on Cancer during November 11-12, 2020 at Tokyo, Japan; International Conference on Cancer Diagnosis & Treatment during April 22-23, 2020 at Florence, Italy; 40th Euro Congress on Cancer Science & Therapy during May 25-26, 2020 at Rome, Italy; Experts Meeting on Cancer Medicine, Radiology & Treatment during June 29-30,2020 at Athens, Greece;16th World Congress on Blood Cancer during September 14-15, 2020 at Vienna, Austria; International Conference on Frontiers in Lung Cancer during November 16-17, 2020 at Brisbane, Australia;

Track 2: Cancer & Stem Cell Therapy

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Stem Cells and Tumours cancer cells also have the characteristic which is also associated with normal stems cells. Stem Cell Therapy is using to prevent the disease. Stems cells transplant is used to treatment of cancer like leukaemia, multiple myeloma & lymphoma. Cord Blood Stem and Cancer cord blood contains haematopoietic (blood) stem cell. They have long been used in stem cell treatments for leukaemia, blood and bone marrow disorders when chemotherapy is used.
Related Conferences

18th Asia Pacific Oncologists Annual Meeting during June 22-23, 2020 at Brisbane, Australia; 2nd International Conference on Biomarkers and Cancer Targets during  May 27-28, 2020 at  Istanbul, Turkey; 7th World Congress on Epigenetics and Chromosome during June 24-25, 2020 at Zurich, Switzerland;27th Cancer Genomics Congress: New Era for Cancer Prevention during July 15-16, 2020 at Helsinki, Finland; 20th Global Cancer Summit during March 30-31, 2020 at Kyoto, Japan; 10th World Congress on Breast Cancer & Therapies during June 11-12, 2020 at Singapore;

Track 3: Organ-Defined Cancers

Cancer can occur anywhere in the body. The most common sites of cancer among men include lung, prostate, colon, rectum, stomach and liver. And those for among women are breast, colon, rectum, lung, cervix and stomach. Cancers are often described by the body part that they originated in. However, some body parts contain multiple types of tissue, so for greater precision, cancers can additionally be classified by the type of cell that the tumour cells originated from. The type of cancer a person has needed to be known properly as different types of cancer can behave very differently and respond to different treatments.

Related Conferences

1th Euro Breast Cancer Summit during April 29-30, 2020 at Prague, Czech Republic;  5th World Congress on Cancer and Diagnostics during June 15-16, 2020 at Berlin, Germany; 32nd International Conference on Cancer Research and Therapy during February 19-20-2020 at Osaka, Japan;  4th Global Summit on Cancer during November 11-12, 2020 at Tokyo, Japan; 16th World Congress on Blood Cancer during September 14-15, 2020 at Vienna, Austria; International Conference on Frontiers in Lung Cancer during November 16-17, 2020 at Brisbane, Australia

Track 4: Cancer Biomarkers

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumour or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycolic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. While some cancer biomarkers can be used to predict how aggressively your cancer will grow, and are therefore useful for assessing your prognosis, the most promising use of biomarkers today is to identify which therapies a patient’s cancer may or may not respond to.

Related Conferences:

18th Asia Pacific Oncologists Annual Meeting during June 22-23, 2020 at Brisbane, Australia; 2nd International Conference on Biomarkers and Cancer Targets during  May 27-28, 2020 at  Istanbul, Turkey; 40th Euro Congress on Cancer Science & Therapy during May 25-26, 2020 at Rome, Italy; 11th Euro Breast Cancer Summit during April 29-30, 2020 at Prague, Czech Republic; 20th Global Cancer Summit during March 30-31, 2020 at Kyoto, Japan; 10th World Congress on Breast Cancer & Therapies during June 11-12, 2020 at Singapore

Track 5: Cancer Vaccines

Cancer vaccines generally either treats existing cancer or prevents development of a cancer. Cancer treatment vaccines are made up of cancer cells, parts of cells, or pure antigens. Sometimes a patient’s own immune cells are removed and exposed to these substances in the lab to create the vaccines. 

Related Conferences:

7th World Congress on Epigenetics and Chromosome during June 24-25, 2020 at Zurich, Switzerland; 27th Cancer Genomics Congress: New Era for Cancer Prevention during July 15-16, 2020 at Helsinki, Finland; International Conference on Frontiers in Lung Cancer during November 16-17, 2020 at Brisbane, Australia; 18th Asia Pacific Oncologists Annual Meeting during June 22-23, 2020 at Brisbane, Australia; 10th World Congress on Breast Cancer & Therapies during June 11-12, 2020 at Singapore

Track 6: Cancer Nanotechnology

The traditional use of nanotechnology in cancer therapeutics has been to improve the pharmacokinetics and reduce the systemic toxicities of chemotherapies through the selective targeting and delivery of these anticancer drugs to tumor tissues.

40th Euro Congress on Cancer Science & Therapy during May 25-26, 2020 at Rome, Italy;  11th Euro Breast Cancer Summit during April 29-30, 2020 at Prague, Czech Republic;  5th World Congress on Cancer and Diagnostics during June 15-16, 2020 at Berlin, Germany; International Conference on Frontiers in Lung Cancer during November 16-17, 2020 at Brisbane, Australia; 18th Asia Pacific Oncologists Annual Meeting during June 22-23, 2020 at Brisbane, Australia; 20th Global Cancer Summit during March 30-31, 2020 at Kyoto, Japan

Track 7: Cancer Pharmacology

Cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches. It also focuses on developing experimental approaches to the clinical treatment of cancer through research that bridges the fields of molecular carcinogenesis, biochemical pharmacology, radiation biology, and clinical pharmacology. It generally involves the pharmacological and oncological aspects of drugs at both.

Related Conferences:

27th Cancer Genomics Congress: New Era for Cancer Prevention during July 15-16, 2020 at Helsinki, Finland; International Conference on Cancer Diagnosis & Treatment during April 22-23, 2020 at Florence, Italy; 5th World Congress on Cancer and Diagnostics during June 15-16, 2020 at Berlin, Germany; 20th Global Cancer Summit during March 30-31, 2020 at Kyoto, Japan; 10th World Congress on Breast Cancer & Therapies during June 11-12, 2020 at Singapore; 2nd International Conference on Biomarkers and Cancer Targets during  May 27-28, 2020 at  Istanbul, Turkey

Track 8: Cancer Chemotherapy

Chemotherapy is a type of cancer treatment that uses one or more anti-cancer drugs as part of a standardized chemotherapy regimen. Chemotherapy may be given with a curative intent, or it may aim to prolong life or to reduce symptoms.

Related Conferences:

32nd International Conference on Cancer Research and Therapy during February 19-20-2020 at Osaka, Japan; International Conference on Cancer Diagnosis & Treatment during April 22-23, 2020 at Florence, Italy; Experts Meeting on Cancer Medicine, Radiology & Treatment during June 29-30,2020 at Athens, Greece; 2nd International Conference on Biomarkers and Cancer Targets during  May 27-28, 2020 at  Istanbul, Turkey; 27th Cancer Genomics Congress: New Era for Cancer Prevention during July 15-16, 2020 at Helsinki, Finland

Track 9: Oncology: Sub-Specialities

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Different cancers affecting different parts of the body e.g. breast, prostate, lungs, blood cells (leukaemia) or other organs behave in different manner, are of different grades and cellular type, respond differently to treatment and have different set of effective treatment regimen. An oncologist is a doctor who treats cancer. Within oncology there are several sub-specialities that deal with different types of cancer.

Related Conferences:

4th Global Summit on Cancer during November 11-12, 2020 at Tokyo, Japan; 20th Global Cancer Summit during March 30-31, 2020 at Kyoto, Japan; 11th Euro Breast Cancer Summit during April 29-30, 2020 at Prague, Czech Republic;  5th World Congress on Cancer and Diagnostics during June 15-16, 2020 at Berlin, Germany; 16th World Congress on Blood Cancer during September 14-15, 2020 at Vienna, Austria; International Conference on Frontiers in Lung Cancer during November 16-17, 2020 at Brisbane, Australia

Track 10: Precision Cancer Medicine & Oncology

Precision medicine is the tailoring of medical treatment to the individual characteristics of each patient and his or her disease. Moreover, through the precision medicine approach, the treatment of each patient can be focused on drugs most likely to benefit him or her, sparing the patient the cost and potential harmful side effects from drugs that are unlikely to be beneficial. Oncology has been leading precision medicine efforts largely because of our immense knowledge of the role of genetic mutations in the development and progression of cancer. Precision medicine enables to approach detection, diagnosis and treatment in an in-depth way to determine how a cancer develops, grows and spreads. 

Related Conferences:

18th Asia Pacific Oncologists Annual Meeting during June 22-23, 2020 at Brisbane, Australia; 5th World Congress on Cancer and Diagnostics during June 15-16, 2020 at Berlin, Germany; 7th World Congress on Epigenetics and Chromosome during June 24-25, 2020 at Zurich, Switzerland; 20th Global Cancer Summit during March 30-31, 2020 at Kyoto, Japan; 10th World Congress on Breast Cancer & Therapies during June 11-12, 2020 at Singapore

Track 11: Cancer Epidemiology

Cancer Epidemiology includes the study of the factors affecting cancer, to infer possible trends and causes. The study of cancer epidemiology uses epidemiological methods to find the cause of cancer and to identify and develop improved treatments. It can be used to identify events that increase or decrease cancer incidence in specific populations. The studies related to population-based research on cancer etiology, prevention, surveillance and survivorship, analytical, and molecular epidemiology, survivorship studies, risk factors, as well as the role of behavioural factors in cancer etiology and prevention are also included.

Related Conferences:

20th Global Cancer Summit during March 30-31, 2020 at Kyoto, Japan;  10th World Congress on Breast Cancer & Therapies during June 11-12, 2020 at Singapore; 11th Euro Breast Cancer Summit during April 29-30, 2020 at Prague, Czech Republic; 5th World Congress on Cancer and Diagnostics during June 15-16, 2020 at Berlin, Germany;7th World Congress on Epigenetics and Chromosome during June 24-25, 2020 at Zurich, Switzerland; 18th Asia Pacific Oncologists Annual Meeting during June 22-23, 2020 at Brisbane, Australia

Track 12: Cancer Therapy & Treatments

Cancer can be treated by different processes. The choice of therapy depends upon the location and grade of the tumour and the stage of the disease, as well as the general state of the patient). Many experimental cancer treatments are also under development. Some people with cancer will have only one treatment. But most people have a combination of treatments, such as surgery with chemotherapy and/or radiation therapy. You may also have immunotherapy, targeted therapy, or hormone therapy.

Related Conferences:

International Conference on Frontiers in Lung Cancer during November 16-17, 2020 at Brisbane, Australia; Experts Meeting on Cancer Medicine, Radiology & Treatment during June 29-30,2020 at Athens, Greece; 2nd International Conference on Biomarkers and Cancer Targets during  May 27-28, 2020 at  Istanbul, Turkey; International Conference on Cancer Diagnosis & Treatment during April 22-23, 2020 at Florence, Italy; 32nd International Conference on Cancer Research and Therapy during February 19-20-2020 at Osaka, Japan

Track 13: Cancer Immunology & Immunotherapy

Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells (also called tumours or malignancies). It is a field of research that aims to discover cancer immunotherapies to treat and retard progression of the disease. Cancer immunotherapy also known as Immuno-oncology is the use of the immune system to treat cancer. Immunotherapies can be categorized as active, passive or hybrid (active and passive). The immune response, including the recognition of cancer-specific antigens, forms the basis of targeted therapy (such as vaccines and antibody therapies) and tumour marker-based diagnostic tests.

Related Conferences:

10th World Congress on Breast Cancer & Therapies during June 11-12, 2020 at Singapore; 4th Global Summit on Cancer during November 11-12, 2020 at Tokyo, Japan; 27th Cancer Genomics Congress: New Era for Cancer Prevention during July 15-16, 2020 at Helsinki, Finland; 11th Euro Breast Cancer Summit during April 29-30, 2020 at Prague, Czech Republic; 40th Euro Congress on Cancer Science & Therapy during May 25-26, 2020 at Rome, Italy; 2nd International Conference on Biomarkers and Cancer Targets during  May 27-28, 2020 at  Istanbul, Turkey

Track 14: Oncology Nursing and Care

Oncology Nursing is a field involving practice encompasses the roles of direct caregiver, educator, consultant, administrator, and researcher. Oncology and cancer nursing extends to all care delivery settings where clients experiencing or at risk for developing cancer receive health care, education, and counselling for cancer prevention, screening and detection. It also involves appropriate screenings and other preventative practices, symptom management, care to retain as much normal functioning as possible, and supportive measures upon end of life.

Related Conferences:

7th World Congress on Epigenetics and Chromosome during June 24-25, 2020 at Zurich, Switzerland; 5th World Congress on Cancer and Diagnostics during June 15-16, 2020 at Berlin, Germany; 40th Euro Congress on Cancer Science & Therapy during May 25-26, 2020 at Rome, Italy; 32nd International Conference on Cancer Research and Therapy during February 19-20-2020 at Osaka, Japan; Experts Meeting on Cancer Medicine, Radiology & Treatment during June 29-30,2020 at Athens, Greece; 18th Asia Pacific Oncologists Annual Meeting during June 22-23, 2020 at Brisbane, Australia

Track 15: Complementary & Alternative Methods and Cancer

Alternative cancer treatments may not play a direct role in curing your cancer, but they may help you cope with signs and symptoms caused by cancer and cancer treatments. CAM is the term for medical products and practices that are not part of standard care. Integrating the best of evidence-based complementary and alternative cancer treatments with the treatments you receive from your doctor may help relieve many of the symptoms associated with cancer and its treatment.

Related Conferences:

27th Cancer Genomics Congress: New Era for Cancer Prevention during July 15-16, 2020 at Helsinki, Finland; 2nd International Conference on Biomarkers and Cancer Targets during  May 27-28, 2020 at  Istanbul, Turkey; 10th World Congress on Breast Cancer & Therapies during June 11-12, 2020 at Singapore; 32nd International Conference on Cancer Research and Therapy during February 19-20-2020 at Osaka, Japan; International Conference on Cancer Diagnosis & Treatment during April 22-23, 2020 at Florence, Italy; Experts Meeting on Cancer Medicine, Radiology & Treatment during June 29-30,2020 at Athens, Greece

Track 16: Cancer Prevention & Research

Cancer prevention is defined as active measures to decrease the risk of cancer. Most of cancer cases are due to environmental risk factors, and many, but not all, of these environmental factors are controllable lifestyle choices. An individual's risk of developing cancer can be substantially reduced by healthy behaviour. Cancer Prevention Research comprises preclinical, clinical and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences.

Related Conferences:

32nd International Conference on Cancer Research and Therapy during February 19-20-2020 at Osaka, Japan; International Conference on Cancer Diagnosis & Treatment during April 22-23, 2020 at Florence, Italy; Experts Meeting on Cancer Medicine, Radiology & Treatment during June 29-30,2020 at Athens, Greece; 2nd International Conference on Biomarkers and Cancer Targets during  May 27-28, 2020 at  Istanbul, Turkey; 27th Cancer Genomics Congress: New Era for Cancer Prevention during July 15-16, 2020 at Helsinki, Finland

Track 17: Cancer: Lifestyle Connection and Nutrition

Many factors influence the development of cancer. Over the last 25 years, science has shown that diet, physical activity, and body weight—especially being overweight or obese—are major risk factors for developing certain types of cancer. Around a third of the most common cancers could be prevented through lifestyle changes. The main behavioural and environmental risk factors for cancer mortality in the world are related to diet and physical inactivity, use of addictive substances, sexual and reproductive health and exposure to air pollution and use of contaminated needles. The body’s ability to resist cancer may be helped by following a healthy diet, staying physically active, and avoiding excess body fat.  Cancer and cancer treatments can also affect your body's ability to tolerate certain foods and use nutrients.

Related Conferences:

4th Global Summit on Cancer during November 11-12, 2020 at Tokyo, Japan; 20th Global Cancer Summit during March 30-31, 2020 at Kyoto, Japan; 11th Euro Breast Cancer Summit during April 29-30, 2020 at Prague, Czech Republic;  5th World Congress on Cancer and Diagnostics during June 15-16, 2020 at Berlin, Germany; 16th World Congress on Blood Cancer during September 14-15, 2020 at Vienna, Austria; International Conference on Frontiers in Lung Cancer during November 16-17, 2020 at Brisbane, Australia

Track 18: Tumour Virology, Immunology & Cellular Pathology

Tumour virology deals with the specific virus infections and cancer, oncogenes, tumour suppressors, oncogenic cofactors, disruption of innate/ adaptive immune responses, latency, and viral mimicry/piracy of cellular regulatory genes, genomic instability and role of non-coding RNAs in viral pathogenesis. The purpose of this study is to develop viral vectors for human cancer gene therapy and to progress vaccine strategies for treatment of viral-associated cancers. Several methods are being trailed including genetic immunization with recombinant viral vectors based on Semliki Forest virus, immune checkpoint inhibitors and strategies to re-modulate the immunosuppressive tumor environment.

Cancer immunology is an interdisciplinary branch of biology that is concerned with understanding the role of the immune system in the progression and development of cancer; the most well known application is cancer immunotherapy, which utilises the immune system as a treatment for cancer.

Cytopathology is a branch of pathology that studies and diagnoses diseases on the cellular level. The discipline was founded by George Nicolas Papanicolaou in 1928. Cytopathology is generally used on samples of free cells or tissue fragments, in contrast to histopathology, which studies whole tissues.

Related Conferences:

18th Asia Pacific Oncologists Annual Meeting during June 22-23, 2020 at Brisbane, Australia; 5th World Congress on Cancer and Diagnostics during June 15-16, 2020 at Berlin, Germany; 7th World Congress on Epigenetics and Chromosome during June 24-25, 2020 at Zurich, Switzerland; 20th Global Cancer Summit during March 30-31, 2020 at Kyoto, Japan; 10th World Congress on Breast Cancer & Therapies during June 11-12, 2020 at Singapore

Track 19: Cancer Metabolomics

Cancer genomics deals with the characterization difference between the cancer cells and normal cells based on gene expression and sequence of the DNA. The purpose of this study is to understand the basic genetics of tumor progression, development of genome of cancer by mutation and the action of drug in the cancer micro environment.  Metabolomics is the study of the chemical fingerprints left by a metabolite during metabolism. In case of cancer cells, it will be very useful to study the metabolite profile for drug development. Many discoveries are being made in cancer metabolomics, one of them is the noninvasive validation of metabolic biomarkers from the body fluid of cancer patients. Cancer Cell Biology makes the better understanding of the chemical changes happening inside cancer cells. Cancer Science Conferences provides a multidisciplinary knowledge to cancer researchers.

Related Conferences:

20th Global Cancer Summit during March 30-31, 2020 at Kyoto, Japan;  10th World Congress on Breast Cancer & Therapies during June 11-12, 2020 at Singapore; 11th Euro Breast Cancer Summit during April 29-30, 2020 at Prague, Czech Republic; 5th World Congress on Cancer and Diagnostics during June 15-16, 2020 at Berlin, Germany;7th World Congress on Epigenetics and Chromosome during June 24-25, 2020 at Zurich, Switzerland; 18th Asia Pacific Oncologists Annual Meeting during June 22-23, 2020 at Brisbane, Australia

Track 20: Neonatal & Paediatric Oncology

Neonatal & Pediatric Oncology is the term used to comprise all malignant conditions among neonates & children with cancer. The most common childhood cancers are leukaemia (begins in blood-forming tissue such as bone marrow), lymphoma (cancer in the cells of immune system), neuroblastoma (nerve cells), retinoblastoma (occurs in the tissues of the retina), Wilms tumour (kidney cancer), and brain tumors, such as gliomas. Childhood cancers are very rare and may differ from adult cancers in the way they grow, spread, treated, and respond to treatment.

Related Conferences:

International Conference on Frontiers in Lung Cancer during November 16-17, 2020 at Brisbane, Australia; Experts Meeting on Cancer Medicine, Radiology & Treatment during June 29-30,2020 at Athens, Greece; 2nd International Conference on Biomarkers and Cancer Targets during  May 27-28, 2020 at  Istanbul, Turkey; International Conference on Cancer Diagnosis & Treatment during April 22-23, 2020 at Florence, Italy; 32nd International Conference on Cancer Research and Therapy during February 19-20-2020 at Osaka, Japan

Track 21: Cancer: Psychological & Social Aspects

If one is fighting cancer, it is not uncommon to experience psychological distress. Whether it is coping with the diagnosis, the challenges of treatment, or continued worry about a recurrence, emotions brought on by the cancer experience can be difficult to handle. Cancer’s effects are far more than physical. Many survivors find that cancer’s impact spills over into the emotional, psychological and spiritual realms. This might happen either during or right after treatment - or not for years.

Related Conferences:

10th World Congress on Breast Cancer & Therapies during June 11-12, 2020 at Singapore; 4th Global Summit on Cancer during November 11-12, 2020 at Tokyo, Japan; 27th Cancer Genomics Congress: New Era for Cancer Prevention during July 15-16, 2020 at Helsinki, Finland; 11th Euro Breast Cancer Summit during April 29-30, 2020 at Prague, Czech Republic; 40th Euro Congress on Cancer Science & Therapy during May 25-26, 2020 at Rome, Italy; 2nd International Conference on Biomarkers and Cancer Targets during  May 27-28, 2020 at  Istanbul, Turkey

Track 22: Cancer Awareness and Survival

Increased cancer awareness improves survival. Social and Economic Impact also harm the quality of cancer care. People who are not financially not strong do not receive good treatment. Cancer symptom awareness and cancer survival are associated. Cancer Awareness Program is conducted by government and many organizations to bring the awareness in the people to decrease the cancer levels & towards all oncology programs. Campaigns should focus on improving awareness about cancer symptoms, especially in socioeconomically deprived areas.

Related Conferences:

7th World Congress on Epigenetics and Chromosome during June 24-25, 2020 at Zurich, Switzerland; 5th World Congress on Cancer and Diagnostics during June 15-16, 2020 at Berlin, Germany; 40th Euro Congress on Cancer Science & Therapy during May 25-26, 2020 at Rome, Italy; 32nd International Conference on Cancer Research and Therapy during February 19-20-2020 at Osaka, Japan; Experts Meeting on Cancer Medicine, Radiology & Treatment during June 29-30,2020 at Athens, Greece; 18th Asia Pacific Oncologists Annual Meeting during June 22-23, 2020 at Brisbane, Australia

Track 23: Cancer Biopsy

A biopsy is a medical examination usually done by a surgeon, an interventional radiologist, or an interventional cardiologist concerning extraction of sample cells or tissues for scrutiny to determine the existence of a disease state. Mainly the biopsy is of two categories, the excisional biopsy in which the affected tissues or cells are removed entirely and the incisional biopsy in which some sample is extracted from the affected region for diagnosis. When cancer is suspected, the first attempt will be excisional biopsy if it doesn’t work they will go for incisional biopsy to determine whether the cancer is benign or malignant. Sometimes in biopsy if the area of suspicion is not found, X- rays or ultrasound can be used to trace the area it is known as ultra sound guided biopsy or stereotactic guided biopsy. The safest mode of diagnosis and a minor surgical procedure is called fine needle aspiration. A noninvasive method of diagnosing cancer is liquid biopsy. Cancer pathogenesis is considered as a most important procedure after biopsy. Oncology - Clinical Trials, in which the biopsy is considered as an important technique. Cancer Science and Therapy Conferences paves a way towards a break-through in cancer research field. 

Related Conferences:

27th Cancer Genomics Congress: New Era for Cancer Prevention during July 15-16, 2020 at Helsinki, Finland; 2nd International Conference on Biomarkers and Cancer Targets during  May 27-28, 2020 at  Istanbul, Turkey; 10th World Congress on Breast Cancer & Therapies during June 11-12, 2020 at Singapore; 32nd International Conference on Cancer Research and Therapy during February 19-20-2020 at Osaka, Japan; International Conference on Cancer Diagnosis & Treatment during April 22-23, 2020 at Florence, Italy; Experts Meeting on Cancer Medicine, Radiology & Treatment during June 29-30,2020 at Athens, Greece

Track 24: Cancer Metastasis

The spread of cancer from one part of the body to another part or to lymph nodes, which are not directly connected to each other is called cancer metastasis. Cancer is considered as a deadly disease mainly because of its ability to spread in the body. This metastasis takes place through the blood stream or the lymph system. The most common metastasis parts of the body are the lungs, bones, liver and brain. The metastatic cancer cells does not resemble the feature of the cells where it was found but it resembles the primary cancer cells i.e. it was considered as a next stage of the primary cancer cells. All metastatic cancers are considered as advanced cancers. The cancer survival and treatment is influenced by whether the cancer cells are localized or spreads to other parts. When the cancer starts to spread it is very difficult to control. Even if the treatment is continued, it will be only palliative care. The pain killing will be mostly by Anti-cancer drugs i.e. chemotherapy. Cancer Management is a multidisciplinary approach that deals with the various type of cancer complications and its preventive measures. Cancer Conferences is an important key for both educational and clinical guidance for managing cancer patients.

Related Conferences:

32nd International Conference on Cancer Research and Therapy during February 19-20-2020 at Osaka, Japan; International Conference on Cancer Diagnosis & Treatment during April 22-23, 2020 at Florence, Italy; Experts Meeting on Cancer Medicine, Radiology & Treatment during June 29-30,2020 at Athens, Greece; 2nd International Conference on Biomarkers and Cancer Targets during  May 27-28, 2020 at  Istanbul, Turkey; 27th Cancer Genomics Congress: New Era for Cancer Prevention during July 15-16, 2020 at Helsinki, Finland

Market Analysis

Cancer is the second leading cause of death worldwide. It’s crucial to remember that cancer is not one disease – it’s more than 200 cancer diseases involved. All different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working. Only worldwide research will enhance our understanding of cancer and help us find and develop better, more effective treatments. And only a global search for answers will help us get to grips with this disease. . The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer (or) oncology

World Cancer 2019 will also explore the new ideas and concepts on global scale and the topics Cancer Biology & Genetics, Organ-Defined Cancers, Oncology: Sub-Specialities, Radiation Oncology, Surgical Oncology, Cancer & Stem Cell Therapy, Precision Cancer Medicine & Oncology, Cancer Biomarkers, Cancer Epidemiology, Cancer Prevention & Research, Cancer Therapy & Treatments, Cancer Pharmacology, Cancer Vaccines, Cancer Immunology & Immunotherapy, Oncology Nursing and Care, Complementary & Alternative Methods and Cancer, Cancer Awareness and Survival, Cancer: Lifestyle and Nutrition, Cancer: Psychological & Social Aspects

Why Rome…?

Rome is the capital city of Italy and of the Lazio region. With 2.9 million residents in 1,285 km2 (496.1 sq mi), it is also the country's largest and most populated commune and fourth-most populous city in the European Union by opulation within city limits. The Metropolitan City of Rome has a population of 4.3 million residents. The city is located in the central-western portion of the Italian Peninsula, within Lazio (Latium), along the shores of Tiber River.

Rome a gorgeous city with many hidden secrets poses one of the world’s most promising destinations   to visit and experience the special tourist attractions. Attending and contributing to the conference will definitely enhance your cultural and scientific experience and open further opportunities for you and your career.

Target Audience

Professors, Director’s, Research scholars, Industrial professionals, Biomedical and healthcare sectors, Oncologists, Pathologists, Haematologists, Immunologists, Clinical Researchers, Scientists, Business Entrepreneurs, Training Institutes, Cancer research Students, Cancer Research Faculty, Cancer Researchers, Gynaecologists, Obstetricians, Medical Colleges, Cancer Associations and Societies, Physicians, Healthcare Scientists and Professors, Breast Cancer Surgeons, Pathologists, Radiologists, Nurse Practitioners/Nurses, Chemotherapists, Medical Devices Manufacturing Companies, Pharmaceutical Companies, Diagnostics Companies, Business Entrepreneurs, leading pharmaceutical leaders, doctors, health care professionals, molecular diagnosticians, clinicians, researchers, Executives/Managers and Business Delegates, Universities, Industries, Investigators, Post-Doctoral Fellows, Research & Diagnostic Laboratories, Clinical Fellows, Biomedical Research organizations.

Glance at the Market

The recent advancements in the cancer treatments & cancer care are accelerating. A cluster of innovative treatments, often combined with other new or existing medicines, and frequently associated with biomarkers, are emerging from the research and development pipeline.

Over the past five years, 70 new oncology treatments have been launched and are being used to treat over 20 different tumour types.

The global cancer biomarker market size was valued at USD 10.3 billion in the year 2016 and is estimated to reach a value of USD 33.7 billion by 2025, growing with CAGR of 14.3 %. Growing prevalence of malignancies coupled with increasing focus on development of targeted therapies is a major factor affirming growth of this market.

Global cancer drugs market accounted for $78,238.9 million in 2015. The cancer drugs market is driven by the growing prevalence of various types of cancer, increasing demand of biological and targeted drug therapies, continuous patent expiry of key cancer drugs and the rising impact of bio similars. Global Oncology/Cancer Drugs Market is expected to garner $111.9 billion by 2020, registering a CAGR of 7.1% during the forecast period 2014 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumour cell specific genes.

The global cancer diagnostics market is segmented based on technology, application, and region.

This report studies the global cancer diagnostics market for the forecast period of 2015 to 2020. This market is expected to reach $13.1 Billion by 2020 from $7.1 Billion in 2015, and is poised to grow at a CAGR of 12.9% during the forecast period.

Past Conference Report

World Cancer 2019

Thanks to all our Speakers and conference attendees of Euro Cancer 2019 Conference

34^th Euro-Global Summit on Cancer Therapy & Radiation Oncology during July 25-27, 2019 at London, UK. The conference organized with a focus on “Advancement in Cancer Research and Prospects of New Therapeutic Strategies” was a great success where eminent keynote speakers from various reputed institutions with their magnificent presence addressed the gathering.

The conference was commenced with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promote the theme with their elegant talk were:

Carina Mari Aparici	University of California, USA
Olivier E Pardo	Imperial College London, UK
Xinzhong Li	Teesside University, UK
Qingyong Ma	First Affiliated Hospital-Xi’an Jiaotong University, China
Gabor Somlyai	HYD LLC for Cancer Research and Drug Development, Hungary
J C Hahne	The Institute of Cancer Research, UK
Emmanouil Karteris	Brunel University, UK

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Euro Cancer 2019, we would like to announce the commencement of the “39th World Cancer Conference” to be held during November 25-26, 2020 at Rome, Italy. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Oncology Research.

For more details: https://cancer.global-summit.com/

Past Reports  Gallery